Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.055 | 0.7 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.061 | 0.7 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |